Jeffrey S. Aronin
Jeff Aronin is Chairman and CEO of Paragon Biosciences. Since 2010 Mr. Aronin has been chairman and chief executive officer of Paragon Biosciences, a global healthcare development and biopharmaceutical investment firm. He has been chairman of several Paragon portfolio companies including Castle Creek Pharmaceuticals, Harmony Biosciences and previously Marathon Pharma, a research based prescription biopharmaceutical company.
From 2000 to 2009, Mr. Aronin was president and chief executive officer of Ovation Pharmaceuticals Inc., a biopharmaceutical company he founded in 2000. In 2009, Ovation Pharmaceuticals was acquired by Lundbeck, Inc. Mr. Aronin served as president and chief executive officer of Lundbeck, Inc. during its acquisition and integration of Ovation Pharmaceuticals.
Mr. Aronin has experience as a chief executive officer leading several global biopharmaceutical companies. His skills include strategic and business development, finance and brand marketing. He brings valuable leadership experience and knowledge in the operations and day-to-day management of a global corporation in a regulated industry. Mr. Aronin also has experience in the structuring and execution of strategic corporate transactions, including mergers and acquisitions.